Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Fatigue
Interventions: DIETARY_SUPPLEMENT: TW1025|DIETARY_SUPPLEMENT: Placebo
Sponsor: Meriyana Bio Inc.
Collaborators: US Oncology Research